Analysts Positive On Keryx Biopharmaceuticals, Inc. Despite Weak Prescription Data By: TalkMarkets May 05, 2015 at 12:24 PM EDT Keryx posted total revenue of $1.175 million, including 1,218 prescriptions filled for Auryxia in the quarter. Read More >> Related Stocks: Keryx Biopharm Inc